Interventional Pulmonology Market: Introduction
According to the report, the global interventional pulmonology market was valued over US$ 3 Bn in 2024 and is projected to expand at a CAGR of ~9% from 2024 to 2031. Interventional pulmonology uses endoscopy and other tools to diagnose and treat conditions in the lungs and chest by using minimally invasive techniques. Rise in prevalence of respiratory disorders, increase in geriatric population, and surge in incidence of diseases that require endoscopic ultrasound procedures are the major factors anticipated to drive the global interventional pulmonology market during the forecast period.
North America held a major share of the global interventional pulmonology market in 2024 due to the high demand for interventional pulmonology devices. Additionally, technological advancements drive demand for interventional pulmonology devices, which is expected to augment the market in the region. The interventional pulmonology market in Asia Pacific is likely to expand at a high CAGR of 9.43% from 2024 to 2031 due to increase in acceptance of technological platforms across various fields.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=61695
Respiratory Endotherapy Devices Dominate Global Market
In terms of product type, the global interventional pulmonology market has been classified into bronchoscopes, electromagnetic navigation bronchoscopy systems, pleuroscopes, respiratory endotherapy devices, airway stents, pleural catheters, endobronchial valves, and bronchial thermoplasty systems. The respiratory endotherapy devices segment dominated the global interventional pulmonology market in 2024 and the trend is projected to continue during the forecast period. Respiratory endotherapy devices are used for bronchoscopic or endoscopic diagnostics and surgery. Devices used in endotherapy include biopsy forceps, cytology brushes, aspiration needles, electrosurgery snares, and foreign body removal tools, guide sheaths, and other similar devices used for respiratory endotherapy procedures.
Asthma Held Major Share of Interventional Pulmonology Market
Based on indication, the global interventional pulmonology market has been categorized into asthma, COPD, lung cancer, tracheal & bronchial stenosis, and others. The asthma segment held major share of the global interventional pulmonology market in 2024. Asthma affects all age groups, but often starts in the childhood. It is a disease characterized by recurrent attacks of breathlessness and wheezing, which vary in severity and frequency from person to person. In an individual, it could occur from hour to hour and day to day.
Request for Analysis of COVID-19 Impact on Interventional Pulmonology Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=61695
Hospitals to be Most Promising End User
In terms of end user, the global interventional pulmonology market has been divided into hospitals, ambulatory surgical centers, diagnostic centers, specialty clinics, and others. The hospitals segment held a major share of the global interventional pulmonology market in 2024.
North America to Dominate Global Market; Asia Pacific to Offer Significant Opportunities
In terms of region, the global interventional pulmonology market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is anticipated to account for a leading share of the global interventional pulmonology market during the forecast period. The interventional pulmonology market in Asia Pacific is expected to grow at a rapid pace in the near future. India and China are likely to be lucrative markets for interventional pulmonology during the forecast period.
Pre Book Interventional Pulmonology Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=61695<ype=S
Growth Strategies of Key Players
Key players operating in the global interventional pulmonology market are Argon Medical, Body Vision Medical Ltd., Boston Scientific Corporation, C. R. Bard, Inc. (Becton, Dickinson and Company), CONMED Corporation, Cook, ENDO-FLEX GmbH, Fujifilm Corporation, KARL STORZ SE & Co. KG, Medtronic, Olympus Corporation, Pennine Healthcare, PENTAX Medical, Pulmonx Corporation, Richard Wolf GmbH, Rocket Medical plc., TAEWOONG, and Vygon, among others. These companies engage in research & development to develop novel products in order to expand product offerings and customer base.
More Trending Reports by Transparency Market Research –
Radiopharmaceutical Market: https://www.prnewswire.com/news-releases/radiopharmaceutical-market-to-reach-valuation-of-us-5-4-bn-by-2027-transparency-market-research-301018881.html
Read our Case study at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
